IL2 and cancer: Radiolabeled IL-2 (e.g., 18F-IL-2) has been used in PET imaging to monitor the activation state and distribution of immune cells, playing a vital role in evaluating cancer patients’ immune responses and optimizing immunotherapy strategies (169).